Literature DB >> 10193407

Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line.

I Tsuge1, T Morishima, M Morita, H Kimura, K Kuzushima, H Matsuoka.   

Abstract

The clinical evidence of a relationship between severe hypersensitivity to mosquito bite (HMB) and clonal expansion of EBV-infected NK cells has been accumulated. In order to clarify the mechanism of EBV-induced NK cell proliferation and its relationship with high incidence of leukaemias or lymphomas in HMB patients, we studied clonally expanded NK cells from three HMB patients and succeeded in establishing an EBV-infected NK-like cell line designated KAI3. Immunoblotting and reverse transcriptase-polymerase chain reaction (RT-PCR) analyses revealed that KAI3 cells as well as infected NK cells exhibited an EBV latent infection type II, where EBV gene expression was limited to EBNA 1 and LMP1. As KAI3 was established by culture with IL-2, IL-2 responsiveness of peripheral blood NK cells from patients was examined. The results represented markedly augmented IL-2-induced IL-2R alpha expression in NK cells. This characteristic property may contribute to the persistent expansion of infected NK cells. However, KAI3 cells as well as the NK cells from patients were not protected from apoptosis induced by either an anti-Fas antibody or NK-sensitive K562 cells. Preserved sensitivity to apoptosis might explain the relatively regulated NK cell numbers in the peripheral blood of the patients. To our knowledge, KAI3 is the first reported NK-like cell line established from patients of severe chronic active EBV infection (SCAEBV) before the onset of leukaemias or lymphomas. KAI3 cells will contribute to the study of EBV persistency in the NK cell environment and its relationship with high incidence of leukaemias or lymphomas in HMB patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10193407      PMCID: PMC1905265          DOI: 10.1046/j.1365-2249.1999.00836.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis.

Authors:  Y Tokura; Y Tamura; M Takigawa; M Koide; T Satoh; T Sakamoto; D Horiguchi; M Yamada
Journal:  Arch Dermatol       Date:  1990-03

2.  Calcification in the basal ganglia with chronic active Epstein-Barr virus infection.

Authors:  M Morita; I Tsuge; H Matsuoka; Y Ito; T Itosu; M Yamamoto; T Morishima
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

3.  EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx.

Authors:  H zur Hausen; H Schulte-Holthausen; G Klein; W Henle; G Henle; P Clifford; L Santesson
Journal:  Nature       Date:  1970-12-12       Impact factor: 49.962

Review 4.  The chronic mononucleosis syndrome.

Authors:  S E Straus
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

5.  A quantitative study of specific immunoglobulins to mosquito salivary gland antigen in hypersensitive and common types of mosquito bite reaction.

Authors:  N Ohtaki; K Oka
Journal:  J Dermatol       Date:  1994-09       Impact factor: 4.005

6.  Evidence for defects in V(D)J rearrangements in patients with severe combined immunodeficiency.

Authors:  T Abe; I Tsuge; Y Kamachi; S Torii; K Utsumi; Y Akahori; Y Ichihara; Y Kurosawa; H Matsuoka
Journal:  J Immunol       Date:  1994-06-01       Impact factor: 5.422

7.  Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infection.

Authors:  H Kimura; I Tsuge; S Imai; M Yamamoto; K Kuzushima; T Osato; T Morishima
Journal:  Med Microbiol Immunol       Date:  1995-08       Impact factor: 3.402

8.  The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor.

Authors:  W E Miller; H S Earp; N Raab-Traub
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease.

Authors:  H Kikuta; Y Taguchi; K Tomizawa; K Kojima; N Kawamura; A Ishizaka; Y Sakiyama; S Matsumoto; S Imai; T Kinoshita
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

10.  Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.

Authors:  M Rowe; D T Rowe; C D Gregory; L S Young; P J Farrell; H Rupani; A B Rickinson
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

View more
  17 in total

1.  An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection.

Authors:  Chongfeng Xu; Junhong Ai; Qingxun Zhang; Ting Li; Xiaorong Wu; Zhengde Xie; Ziyuan Duan
Journal:  J Vis Exp       Date:  2018-03-30       Impact factor: 1.355

Review 2.  Mosquito vectors and the spread of cancer: an overlooked connection?

Authors:  Giovanni Benelli; Annalisa Lo Iacono; Angelo Canale; Heinz Mehlhorn
Journal:  Parasitol Res       Date:  2016-04-07       Impact factor: 2.289

3.  c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma.

Authors:  Takumi Kumai; Yoshinari Matsuda; Takayuki Ohkuri; Kensuke Oikawa; Kei Ishibashi; Naoko Aoki; Shoji Kimura; Yasuaki Harabuchi; Esteban Celis; Hiroya Kobayashi
Journal:  Oncoimmunology       Date:  2015-03-06       Impact factor: 8.110

4.  A case of hypersensitivity to mosquito bite associated with Epstein-barr viral infection and natural killer cell lymphocytosis.

Authors:  Eui Jung Roh; Eun Hee Chung; Young Pyo Chang; Na Hye Myoung; Young Koo Jee; Min Seo; Jin Han Kang
Journal:  J Korean Med Sci       Date:  2010-01-25       Impact factor: 2.153

5.  Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.

Authors:  Michiko K Oyoshi; Hiroshi Nagata; Nobuhiro Kimura; Yu Zhang; Ayako Demachi; Toshiro Hara; Hirokazu Kanegane; Yoshinobu Matsuo; Tomohiro Yamaguchi; Tomohiro Morio; Atsuyoshi Hirano; Norio Shimizu; Kohtaro Yamamoto
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

6.  The Epstein-Barr Virus Enhancer Interaction Landscapes in Virus-Associated Cancer Cell Lines.

Authors:  Weiyue Ding; Chong Wang; Yohei Narita; Hongbo Wang; Merrin Man Long Leong; Alvin Huang; Yifei Liao; Xuefeng Liu; Yusuke Okuno; Hiroshi Kimura; Benjamin Gewurz; Mingxian Teng; Shuilin Jin; Yoshitaka Sato; Bo Zhao
Journal:  J Virol       Date:  2022-09-12       Impact factor: 6.549

7.  Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations.

Authors:  Christopher P Fox; Claire Shannon-Lowe; Martin Rowe
Journal:  Herpesviridae       Date:  2011-09-07

8.  Role of latent membrane protein 1 in chronic active Epstein-Barr virus infection-derived T/NK-cell proliferation.

Authors:  Takuto Ito; Hidetaka Kawazu; Takayuki Murata; Seiko Iwata; Saki Arakawa; Yoshitaka Sato; Kiyotaka Kuzushima; Fumi Goshima; Hiroshi Kimura
Journal:  Cancer Med       Date:  2014-05-03       Impact factor: 4.452

9.  Hypersensitivity to mosquito bites associated with natural killer cell-derived large granular lymphocyte lymphocytosis: a case report in Korea.

Authors:  Joo Seop Chung; Ho Jin Shin; Eun Yup Lee; Goon Jae Cho
Journal:  Korean J Intern Med       Date:  2003-03       Impact factor: 2.884

10.  The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas.

Authors:  Michio Suzuki; Tadashi Takeda; Hikaru Nakagawa; Seiko Iwata; Takahiro Watanabe; Mohammed N A Siddiquey; Fumi Goshima; Takayuki Murata; Jun-Ichi Kawada; Yoshinori Ito; Seiji Kojima; Hiroshi Kimura
Journal:  Front Microbiol       Date:  2015-04-09       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.